Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3335996> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Q3335996 subject Q6938881.
- Q3335996 subject Q7215001.
- Q3335996 subject Q8235433.
- Q3335996 subject Q8662783.
- Q3335996 abstract "Naproxcinod (nitronaproxen) is a non-steroidal anti-inflammatory drug (NSAID) developed by the French pharmaceutical company NicOx. It is a derivative of naproxen with a nitroxybutyl ester to allow it to also act as a nitric oxide (NO) donor. This second mechanism of action makes naproxcinod the first in a new class of drugs, the cyclooxygenase inhibiting nitric oxide donators (CINODs), that are hoped to produce similar analgesic efficacy to traditional NSAIDs, but with less gastrointestinal and cardiovascular side effects.On December 2006, Scientific American distinguished naproxcinod as one of the ten most promising treatments for the world's biggest health threats; however, in 2010 the U.S. Food and Drug Administration determined that further clinical trials would be needed to obtain approval.".
- Q3335996 atcPrefix "M01".
- Q3335996 atcSuffix "AE18".
- Q3335996 chEBI "76254".
- Q3335996 fdaUniiCode "V24GR4LI3I".
- Q3335996 iupacName "4-nitrooxybutyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate".
- Q3335996 pubchem "9884642".
- Q3335996 thumbnail Naproxcinod.png?width=300.
- Q3335996 wikiPageWikiLink Q101487.
- Q3335996 wikiPageWikiLink Q101991.
- Q3335996 wikiPageWikiLink Q1088113.
- Q3335996 wikiPageWikiLink Q1141362.
- Q3335996 wikiPageWikiLink Q12152.
- Q3335996 wikiPageWikiLink Q1215575.
- Q3335996 wikiPageWikiLink Q12202.
- Q3335996 wikiPageWikiLink Q130146.
- Q3335996 wikiPageWikiLink Q14859627.
- Q3335996 wikiPageWikiLink Q173235.
- Q3335996 wikiPageWikiLink Q188724.
- Q3335996 wikiPageWikiLink Q189159.
- Q3335996 wikiPageWikiLink Q204711.
- Q3335996 wikiPageWikiLink Q207843.
- Q3335996 wikiPageWikiLink Q23005640.
- Q3335996 wikiPageWikiLink Q2585693.
- Q3335996 wikiPageWikiLink Q269829.
- Q3335996 wikiPageWikiLink Q2931854.
- Q3335996 wikiPageWikiLink Q30612.
- Q3335996 wikiPageWikiLink Q3271540.
- Q3335996 wikiPageWikiLink Q377458.
- Q3335996 wikiPageWikiLink Q39379.
- Q3335996 wikiPageWikiLink Q408801.
- Q3335996 wikiPageWikiLink Q411412.
- Q3335996 wikiPageWikiLink Q424153.
- Q3335996 wikiPageWikiLink Q4917.
- Q3335996 wikiPageWikiLink Q62736.
- Q3335996 wikiPageWikiLink Q6431240.
- Q3335996 wikiPageWikiLink Q6859652.
- Q3335996 wikiPageWikiLink Q6938881.
- Q3335996 wikiPageWikiLink Q7041506.
- Q3335996 wikiPageWikiLink Q707194.
- Q3335996 wikiPageWikiLink Q721432.
- Q3335996 wikiPageWikiLink Q7215001.
- Q3335996 wikiPageWikiLink Q7916469.
- Q3335996 wikiPageWikiLink Q8235433.
- Q3335996 wikiPageWikiLink Q844935.
- Q3335996 wikiPageWikiLink Q8662783.
- Q3335996 wikiPageWikiLink Q898317.
- Q3335996 wikiPageWikiLink Q906797.
- Q3335996 atcPrefix "M01".
- Q3335996 atcSuffix "AE18".
- Q3335996 chebi "76254".
- Q3335996 iupacName "4".
- Q3335996 pubchem "9884642".
- Q3335996 unii "V24GR4LI3I".
- Q3335996 type ChemicalSubstance.
- Q3335996 type Drug.
- Q3335996 type ChemicalObject.
- Q3335996 type Thing.
- Q3335996 type Q8386.
- Q3335996 comment "Naproxcinod (nitronaproxen) is a non-steroidal anti-inflammatory drug (NSAID) developed by the French pharmaceutical company NicOx. It is a derivative of naproxen with a nitroxybutyl ester to allow it to also act as a nitric oxide (NO) donor.".
- Q3335996 label "Naproxcinod".
- Q3335996 depiction Naproxcinod.png.